A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies
Fig 10
Effect of RIC on intact SDF-1α in humans.
Plasma levels of full-length SDF-1α (quantified using HCI.SDF1α ELISA), decreased significantly in healthy male volunteers subjected to RIC.